Genetic Factors Influencing B-type Natriuretic Peptide Mediated Production of Cyclic Guanosine Mono Phosphate and Blood Pressure Effects in Heart Failure Patients

2015 ◽  
Vol 21 (8) ◽  
pp. S16
Author(s):  
David Lanfear ◽  
Raza Abbas ◽  
Badri Padhukasahasram ◽  
Ramesh C. Gupta ◽  
David Langholz ◽  
...  
2021 ◽  
pp. 45-46
Author(s):  
Shahrukh Khilji ◽  
Bushra Fiza ◽  
Shehreen Akhtar ◽  
Jai Prakash ◽  
Maheep Sinha

INTRODUCTION: Congestive Heart Failure is a complex physiological syndrome caused from structural or functional alterations to the myocardium. Lactate is produced by anaerobic metabolism and is secreted by the Brain-Natriuretic peptide heart ventricles in response to left ventricular stretching or wall tension. AIM: The aim of the study was to evaluate Brain-Natriuretic Peptide, Lactate levels and Blood pressure in Congestive Heart Failure patients and compared them with healthy individual. MATERIALS AND METHODS: Total 80 participants who fullled the inclusion and exclusion criteria were enrolled in the study. They were divided into two group i.e., case and control group. Case group included 40 patients of Congestive Heart Failure, age between 18-65 years and control group comprised of 40 healthy individuals with similar age range. Blood sample were drawn and analyzed for the evaluation of Serum lactate and Brain-Natriuretic Peptide. Blood Pressure was also measured in both the groups. RESULT: The present study has demonstrated that the level of Brain-Natriuretic Peptide and lactate were signicantly high in Congestive heart failure patients when compared with control group. Systolic and Diastolic blood pressure were also higher among patients group. CONCLUSION: The results of the study suggested that the levels of Lactate and Brain-Natriuretic Peptide were high in Congestive heart failure patients when compared with healthy individual. Systolic and Diastolic blood pressure were also higher among patients group. Elevated lactate and Brain-Natriuretic Peptide level can be recommended as useful indicator of poor prognosis and hence can be helpful in early identication of patients at risk.


Diabetes ◽  
1994 ◽  
Vol 43 (12) ◽  
pp. 1445-1449 ◽  
Author(s):  
A. D. Morris ◽  
J. R. Petrie ◽  
S. Ueda ◽  
J. M. Connell ◽  
H. L. Elliott ◽  
...  

2005 ◽  
Vol 99 (3) ◽  
pp. 409-413 ◽  
Author(s):  
Stamos Kyrzopoulos ◽  
Stamatis Adamopoulos ◽  
John T. Parissis ◽  
John Rassias ◽  
George Kostakis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document